Heart failure clinic in a community hospital improves outcome in heart failure patients

Swiss Medical Weekly

Volumn 136, Issue 17-18, 2006, Pages 274-280

  Lainscak, Mitja ^a   Keber, Irena ^b  

^a General Hospital Murska Sobota   (Slovenia)

^b UNIVERSITY MEDICAL CENTRE LJUBLJANA   (Slovenia)

Author keywords

Disease management; Heart failure rehospitalisations; Mortality; Pharmacological therapy; Quality of life

Indexed keywords

ACETYLSALICYLIC ACID; ANGIOTENSIN RECEPTOR ANTAGONIST; ANTICOAGULANT AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BISOPROLOL; CALCIUM ANTAGONIST; CARVEDILOL; DIGOXIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; ENALAPRIL; FUROSEMIDE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; NITRIC ACID DERIVATIVE; PERINDOPRIL; RAMIPRIL; SPIRONOLACTONE; WARFARIN;

ADULT; AGED; ARTICLE; COMMUNITY HOSPITAL; CONFIDENCE INTERVAL; CONTROLLED STUDY; DISEASE CLASSIFICATION; DOSE RESPONSE; DRUG TARGETING; FEMALE; FOLLOW UP; HEALTH CARE; HEALTH CENTER; HEART FAILURE; HOSPITAL READMISSION; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; PATIENT CARE; QUALITY OF LIFE; SYSTOLIC BLOOD PRESSURE; TREATMENT OUTCOME;

EID: 33646839437     PISSN: 14247860     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Cleland JGF, Clark AL. Delivering the cumulative benefits of triple therapy to improve outcomes in heart failure: too many cooks will spoil the broth. J Am Coll Cardiol 2003;42:1234-7.
2. Remme WJ, Swedberg K. Guidelines for the diagnosis and treatment of chronic heart failure. Eur Heart J 2001;22:1527-60.
3. Cleland JGF, Gemmell I, Khand A, Boddy A. Is the prognosis of heart failure improving? Eur J Heart Fail 1999;1:229-41.
4. Schaufelberger M, Swedberg K, Koster M, Rosen M, Rosengren A. Decreasing one-year mortality and hospitalization rates for heart failure in Sweden; Data from the Swedish Hospital Discharge Registry 1988 to 2000. Eur Heart J 2004;25:300-7.
5. Stewart S, MacIntyre K, Hole DJ, Capewell S, McMurray JJ. More malignant than cancer? Five-year survival following a first admission for heart failure. Eur J Heart Fail 2001;3:315-22.
6. Konstam V, Salem D, Pouleur H, Kostis J, Gorkin L, Shumaker S, et al. Baseline quality of life as a predictor of mortality and hospitalizations in 5025 patients with congestive heart failure. Am J Cardiol 1996;78:890-5.
7. Hobbs FDR, Kenkre JE, Roalfe AK, Davis RC, Hare R, Davies MK. Impact of heart failure and left ventricular systolic dysfunction on quality of life - a cross-sectional study comparing common chronic cardiac and medical disorders and a representative adult population. Eur Heart J 2002;23:1867-76.
8. Berry C, Murdoch DR, McMurray JJV. Economics of heart failure. Eur J Heart Fail 2001;3:283-91.
9. Komajda M, Follath F, Swedberg K, Cleland JGF, Aguilar JC, Cohen-Solal A, et al. The EuroHeart Failure survey programme - a survey on the quality of care among patients with heart failure in Europe; Part 2: treatment. Eur Heart J 2003;24:464-75.
10. Rumsfeld JS, Masoudi FA. Heart failure disease management works, but will it succeed? Eur Heart J 2004;25:1565-7.
11. Gonseth J, Guallar-Castillon P, Banegas JR, Rodriguez-Artalejo F. The effectiveness of disease management programmes in reducing hospital re-admissions in older patients with heart failure: a systematic review and meta-analysis of published reports. Eur Heart J 2004;25:1570-95.
12. Phillips CO, Wright SM, Kern DE, Singa RM, Shepperd S, Rubin HR. Comprehensive discharge planning with postdischarge support for older patients with congestive heart failure - a meta-analysis. JAMA 2004;291:1358-67.
13. McAlister FA, Stewart S, Ferma S, McMurray JJV. Multidisciplinary strategies for the management of heart failure patients at high risk for admission: a systematic review of randomized trials. J Am Coll Cardiol 2004;44:810-9.
14. Hershberger RE, Nauman DJ, Byrkit J, Gillespie G, Lackides G, Toy W, et al. Prospective evaluation of an outpatient heart failure disease management program designed for primary care: the Oregon model. J Card Fail 2005;11:293-8.
15. Cleland JGF, Swedberg K, Follath F, Komajda M, Cohen-Solal A, Aguilar JC, et al. The EuroHeart Failure survey programme - a survey on the quality of care among patients with heart failure in Europe; Part 1: patient characteristics and diagnosis. Eur Heart J 2003;24:442-63.
16. Cockroft DW, Gault MH. Prediction of creatinine clearance from serum creatinine. Nephron 1976;16:31-41.
17. Atienza F, Anguita M, Martinez-Alzamora N, Osca J, Ojeda S, Almenar L, et al. Multicenter randomized trial of a comprehensive hospital discharge and outpatient heart failure management program. Eur J Heart Fail 2004;6:643-52.
18. Azevedo A, Pimenta J, Dias P, Bettencourt P, Ferreira A, Cerqueira-Gomes M. Effect of a heart failure clinic on survival and hospital readmissions in patients discharged from acute hospital care. Eur J Heart Fail 2002;4:353-9.
19. Capomolla S, Febo O, Ceresa M, Caporotondi A, Guazzotti G, La Rovere M, et al. Cost/utility ratio in chronic heart failure: comparison between heart failure management program delivered by day-hospital and usual care. J Am Coll Cardiol 2002; 40:1259-66.
20. Stewart S, Horowitz JD. Home-based intervention in congestive heart failure: long-term implications on readmission and survival. Circulation 2002;105:2861-6.
21. Stromberg A, Martensson J, Fridlund B, Levin LA, Karlsson JE, Dahlstrom U. Nurse-led heart failure clinics improve survival and self care behaviour in patients with heart failure. Eur Heart J 2003;24:1014-23.
22. Horwich TB, Fonarow GC, Hamilton MA, MacLellan WR, Borenstein J. Anemia is associated with worse symptoms, greater impairment in functional capacity and a significant increase in mortality in patients with advanced heart failure. J Am Coll Cardiol 2002;39:1780-6.
23. McAlister FA, Ezekowitz J, Tonelli M, Armstrong PW. Renal insufficiency and heart failure: prognostic and therapeutic implications from a prospective cohort study. Circulation 2004; 109:1004-9.
24. Nohria A, Tsang SW, Fang JC, et al. Clinical assessment identifies haemodynamic profiles that predict outcomes in patients admitted with heart failure. J Am Coll Cardiol 2003;41:1797-804.
25. Linne AB, Liedholm II, Jendteg S, Israelsson B. Health care costs of heart failure: results from a randomised study of patient education. Eur J Heart Fail 2000;2:291-7.
26. Kimmelstiel C, Levine D, Perry AR, Patel AR, Sadaniantz A, Gorham N, et al. Randomized, controlled evaluation of short-and long term benefits of heart failure disease management within a diverse provider network: the SPAN-CHF trial. Circulation 2004;110:1450-5.
27. Ryder M, Travers B, Ledwidge M, McDonald K. Multidisciplinary care of heart failure: what have we learned and where can we improve? Eur J Cardiovasc Nurs 2003;2:247-9.
28. Jaarsma T. Heart failure management programs: how far should we go? Eur J Heart Fail 2003;5:215-6.
29. Lainscak M, Horvat A, Keber I. The management of patients with heart failure in Slovenian community hospital: what has changed from 1997 to 2000? Wien Klin Wochenschr 2003;115:334-9.
30. Kuster GM, Tanner H, Printzen G, Suter TM, Mohacsi P, Hess OM. B-type natriuretic peptide for diagnosis and treatment of congestive heart failure. Swiss Med Wkly 2003;133:623-8.
31. Wickstrom G, Bendix T. The «Hawthorne effect» - what did the original Hawthorne studies actually show? Scand J Work Environ Health 2000;26:363-7.